Can This Tiny Biotech Take On Pfizer?

Can This Tiny Biotech Take On Pfizer?

Source: 
Motley Fool
snippet: 
  • Prometheus Biosciences and Pfizer are both developing experimental first-of-their-kind treatments for inflammatory bowel disease.
  • Inflammatory bowel disease candidates from Pfizer and Prometheus Biosciences are similar, but there are a couple of key differences.
  • Prometheus Biosciences' stock price could skyrocket this year if its candidate outperforms Pfizer's candidate.